Back
Day Range
$22.13
$23.46
52-Week Range
$11.86
$31.77
Volume
997,351
50D / 200D Avg
$25.67
/
$21.49
Prev Close
$22.21
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -171.3 | 0.4 |
| P/B | 14.6 | 2.9 |
| ROE % | -9.3 | 3.8 |
| Net Margin % | -4.3 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$33.33
+49.5%
Low: $29.00
High: $37.00
Forward P/E
65.9
Forward EPS
$0.34
EPS Growth (est.)
+0.0%
Est. Revenue
500 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.06
$2.99 – $3.22
|
1.1 B | 2 |
| FY2029 |
$2.63
$2.57 – $2.77
|
920 M | 4 |
| FY2028 |
$1.99
$1.44 – $2.79
|
780 M | 6 |
Key Takeaways
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -6.31M
Capital efficient — spends only 0.18% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)91.34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-9.30%
ROIC-4.68%
Net Margin-4.29%
Op. Margin-3.25%
Safety
Debt / Equity
0.03
Current Ratio3.17
Interest Coverage-1.01
Valuation
P/E Ratio
-171.28
P/B Ratio14.59
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 91.34% | Revenue Growth (3Y) | 151.18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 376.07M | Net Income (TTM) | -16.14M |
| ROE | -9.30% | ROA | -3.73% |
| Gross Margin | 90.24% | Operating Margin | -3.25% |
| Net Margin | -4.29% | Free Cash Flow (TTM) | -6.31M |
| ROIC | -4.68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 3.17 |
| Interest Coverage | -1.01 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -171.28 | P/B Ratio | 14.59 |
| P/S Ratio | 7.35 | PEG Ratio | 2.58 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.76B | Enterprise Value | 2.73B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 376.07M | 196.54M | 59.61M | 3.69M | 0.0 |
| Net Income | -16.14M | -140.04M | -262.14M | -311.46M | -206.36M |
| EPS (Diluted) | -0.13 | -1.16 | -3.78 | -5.66 | -4.17 |
| Gross Profit | 339.38M | 177.41M | 54.62M | 2.93M | -763,000.0 |
| Operating Income | -12.23M | -128.40M | -241.10M | -301.63M | -206.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 432.97M | 348.89M | 341.37M | 449.27M | 408.15M |
| Total Liabilities | 243.49M | 191.35M | 252.70M | 239.69M | 110.48M |
| Shareholders' Equity | 189.48M | 157.54M | 88.67M | 209.58M | 297.68M |
| Total Debt | 6.27M | 110.59M | 205.92M | 202.54M | 77.56M |
| Cash & Equivalents | 42.91M | 71.34M | 88.40M | 53.64M | 97.99M |
| Current Assets | 411.23M | 335.82M | 330.43M | 437.41M | 402.77M |
| Current Liabilities | 129.84M | 81.01M | 46.67M | 37.81M | 33.33M |